Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive approach. Supporters often highlight the potential for meaningful therapeutic outcomes, particularly in diseases where conventional treatments have proven limited. However, this is to consider the substantial financial burden associated with CPI stem cell therapy,